Benitec Biopharma (BNTC) Payables (2025)
Benitec Biopharma (BNTC) reported Payables of $1.0 million for Q4 2025, up 405.47% sequentially from $201000.0 in Q2 2025.
Benitec Biopharma (BNTC) Payables (2025) Analysis & Trends
Benitec Biopharma (BNTC) has 1 years of Payables data on file, last reported at $1.0 million in Q4 2025.
- For the quarter ending Q4 2025, Payables changed N/A year-over-year to $1.0 million; the trailing twelve-month figure through Dec 2025 stood at $1.0 million (changed N/A YoY), and the FY2025 full-year result was $201000.0, changed N/A from the prior year.
- Payables grew to $1.0 million in Q4 2025, from $201000.0 in the prior quarter.
- In the past five years, Payables ranged from a high of $1.0 million in Q4 2025 to a low of $201000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 10.62 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 423.55 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 694,346.76 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.52 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 80.54 Mn |
| 10 | Benitec Biopharma | 46.45 Mn | 46.45 Mn | - | 1.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.02 Mn |
| Jun 30, 2025 | 201,000.00 |